Skip to content Skip to sidebar Skip to footer

Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

605 articles published

Retail

Nick Scali (ASX:NCK) Plunges Despite 36% Profit Jump- Buying Opportunity or Warning Sign?

Nick Scali profit jumps, but the stock slides Nick Scali (ASX: NCK) fell 22% to A$18.48 on Friday, even after delivering one of its best half-year results in years. Group statutory net profit rose 36% to AUD 41 million, ANZ revenue increased 13% to AUD 251.7 million, and the interim dividend lifted 30% to a…

ByUjjwal MaheshwariFebruary 14, 20260Comments

Mining Stocks

South32 (ASX:S32) Beats Profit Estimates by 12.5% and Hikes Dividend- Is It Time to Buy?

South32 Profit Surprise Meets High Expectations South32 (ASX:S32) told two very different stories on Thursday. In the morning, the stock surged to around A$4.91 as investors cheered a strong half-year result. By the close, it had fallen nearly 8 per cent from the high to A$4.52, giving back all its gains. The message was clear:…

ByUjjwal MaheshwariFebruary 13, 20260Comments

Energy Stocks

Origin Energy (ASX:ORG) Surges Despite 45% Profit Drop- Is the Market Right to Be Bullish?

Origin Energy Surges on Upgraded Guidance Origin Energy (ASX: ORG) climbed as much as 8.1 per cent on Thursday after releasing its half-year 2026 results before closing at A$11.56. At first glance, a 45 per cent fall in statutory profit to A$557 million looks worrying. But investors are focusing on the bigger picture rather than…

ByUjjwal MaheshwariFebruary 13, 20260Comments

Mining Stocks

Syrah Resources (ASX:SYR) Climbs 6% as US Graphite Tariff Case Advances- A Speculative Buy for Patient Investors?

Syrah Resources Surges on Tariff Boost Syrah Resources (ASX: SYR) rose 6.4% this week to A$0.25 after the US trade case against Chinese graphite moved closer to a final decision. The US Department of Commerce has confirmed combined anti-dumping and countervailing tariffs of at least 160 per cent on graphite anode material imported from China.…

ByUjjwal MaheshwariFebruary 13, 20260Comments

Retail

Temple & Webster (ASX:TPW) Crashes 33% Despite 20% Revenue Growth- Time to Buy the Dip or Stay Away?

Temple & Webster Slumps on Margin Concerns Temple & Webster (ASX: TPW) was smashed 33% on Thursday, closing at A$7.64 after releasing half-year results that told two very different stories depending on how you read them. On one hand, revenue jumped 20% to AUD 376 million, and the company grabbed a record 2.9% share of…

ByUjjwal MaheshwariFebruary 13, 20260Comments

Property

Centuria Industrial REIT (ASX:CIP) Upgrades Earnings- Is It a Buy at 18% Below Asset Value?

Centuria Industrial Trades at a Big Discount, Despite an Earnings Upgrade Centuria Industrial REIT (ASX: CIP) has delivered something investors don’t often see: a property trust that is growing its earnings, increasing its forecast, and still trading at a discount. The company has raised its expected earnings (FFO) for FY26 to 18.2-18.5 cents per unit,…

ByUjjwal MaheshwariFebruary 12, 20260Comments

Healthcare Stocks

A Blood Test Instead of a Colonoscopy? Rhythm Biosciences (ASX:RHY) Takes Its First Commercial Step

Rhythm Biosciences Starts ColoSTAT Pilot, Revenue Still Unclear Rhythm Biosciences (ASX: RHY) just hit a milestone the market has been waiting for, enrolling its first doctor in the ColoSTAT Access Program, a small pilot program that will test its blood-based bowel cancer screening product in real clinical settings for the first time. The share price…

ByUjjwal MaheshwariFebruary 12, 20260Comments

Mining Stocks

Evolution Mining (ASX:EVN) Surges 9% on Record $767M Profit- So Why Do Most Analysts Still Say Sell?

Evolution Mining Hits Record Profit, But Is It Priced Too High? Evolution Mining (ASX: EVN) shares jumped almost 9% after the company reported the best half-year result in its 14-year history. Net profit more than doubled, rising 110% to AUD 766.6 million, while revenue increased 37% to AUD 2.79 billion. The company also announced a record…

ByUjjwal MaheshwariFebruary 12, 20260Comments

Bank Stocks

Commonwealth Bank (ASX:CBA) Reports 6% Profit Growth and Raises Dividend- Buy, Hold, or Take Profits?

Commonwealth Bank Beats Forecasts, But Is It Too Expensive? Commonwealth Bank (ASX: CBA) shares jumped 6.8% to A$169.56 on Wednesday after the bank reported a strong half-year result that was better than expected. The bank made a cash profit of A$5.45 billion, which is 6% higher than last year and clearly above the A$5.2 billion that…

ByUjjwal MaheshwariFebruary 12, 20260Comments

How Digital Payments Are Changing Australian Casinos

Gaming Stocks

The Shift Toward Digital Currencies in the Australian Casino Sector

The Australian gaming industry is changing rapidly, driven not by new game mechanics or floor designs, but by the underlying financial infrastructure that powers the sector. For decades, ASX-listed gaming giants have relied on traditional banking rails to process billions in turnover. However, as we move through 2026, the friction inherent in legacy financial systems…

ByUjjwal MaheshwariFebruary 11, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

Nick Scali (ASX:NCK) Plunges Despite 36% Profit Jump- Buying Opportunity or Warning Sign?

South32 (ASX:S32) Beats Profit Estimates by 12.5% and Hikes Dividend- Is It Time to Buy?

Origin Energy (ASX:ORG) Surges Despite 45% Profit Drop- Is the Market Right to Be Bullish?

Syrah Resources (ASX:SYR) Climbs 6% as US Graphite Tariff Case Advances- A Speculative Buy for Patient Investors?

Temple & Webster (ASX:TPW) Crashes 33% Despite 20% Revenue Growth- Time to Buy the Dip or Stay Away?

Centuria Industrial REIT (ASX:CIP) Upgrades Earnings- Is It a Buy at 18% Below Asset Value?

A Blood Test Instead of a Colonoscopy? Rhythm Biosciences (ASX:RHY) Takes Its First Commercial Step

Evolution Mining (ASX:EVN) Surges 9% on Record $767M Profit- So Why Do Most Analysts Still Say Sell?

Commonwealth Bank (ASX:CBA) Reports 6% Profit Growth and Raises Dividend- Buy, Hold, or Take Profits?

The Shift Toward Digital Currencies in the Australian Casino Sector

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here